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Anhedonia is a core symptom of multiple psychiatric disorders and has been associated with alterations in brain structure. Genome-
wide association studies suggest that anhedonia is heritable, with a polygenic architecture, but few studies have explored the
association between genetic loading for anhedonia—indexed by polygenic risk scores for anhedonia (PRS-anhedonia)—and
structural brain imaging phenotypes. Here, we investigated how anhedonia and PRS-anhedonia were associated with brain
structure within the UK Biobank cohort. Brain measures (including total grey/white matter volumes, subcortical volumes, cortical
thickness (CT) and white matter integrity) were analysed using linear mixed models in relation to anhedonia and PRS-anhedonia in
19,592 participants (9225 males; mean age= 62.6 years, SD= 7.44). We found that state anhedonia was significantly associated
with reduced total grey matter volume (GMV); increased total white matter volume (WMV); smaller volumes in thalamus and
nucleus accumbens; reduced CT within the paracentral cortex, the opercular part of inferior frontal gyrus, precentral cortex, insula
and rostral anterior cingulate cortex; and poorer integrity of many white matter tracts. PRS-anhedonia was associated with reduced
total GMV; increased total WMV; reduced white matter integrity; and reduced CT within the parahippocampal cortex, superior
temporal gyrus and insula. Overall, both state anhedonia and PRS-anhedonia were associated with individual differences in multiple
brain structures, including within reward-related circuits. These associations may represent vulnerability markers for
psychopathology relevant to a range of psychiatric disorders.
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INTRODUCTION
Anhedonia, defined as subjectively diminished capacity to experi-
ence pleasure, is a transdiagnostic symptom present in several
psychiatric disorders, such as major depressive disorder (MDD) and
schizophrenia [1, 2]. Anhedonia can be both a stable, trait-like
characteristic and a transient state that fluctuates over time and
with severity of psychiatric disorders, such as MDD [3]. In
schizophrenia, trait anhedonia is associated with state anhedonia
and may be independent of negative symptoms, but state
anhedonia is correlated with both negative symptoms and
depression [4]. In recent years, with the development of the
Research Domain Criteria (RDoC) initiative [5], research efforts
focused on transdiagnostic symptoms such as anhedonia have
grown substantially, including progress on describing the under-
lying genetic architecture of anhedonia [6] and related neurobio-
logical markers [7]. Anhedonia represents a promising RDoC
construct with potential to elucidate some of the underlying
biology of psychiatric disorders.
Anhedonia is mainly associated with impairments in reward
processing and frontal-striatal brain circuits [8–10]. Evidence from
neuroimaging studies suggests that alterations in reward-related
regions may contribute to the subjective experience of anhedonia.
Reductions in grey matter volume (GMV) and cortical thickness
(CT) within several brain areas (including caudate, nucleus
accumbens (NAcc), anterior cingulate cortex, prefrontal cortex
and parietal lobe) have been reported in studies of trait anhedonia
in patients with schizophrenia [11], in studies of negative
symptoms of schizophrenia [12, 13], as well as in individuals with
MDD [14]. Within non-clinical populations, trait anhedonia has
been found to be associated with reduced volume in caudate [15]
and NAcc [16]. Similarly, anhedonic depression was associated
with reduced NAcc volume in a non-clinical sample [17]. In
addition, reduced bilateral putamen volume was prospectively
predictive for anhedonia severity while baseline anhedonia,
depression and anxiety symptoms were controlled for [16].
However, null findings have also been reported. Yang et al. [18]
found no correlation between state or trait anhedonia and
prefrontal CT or parietal CT in healthy controls or subjects with
MDD. This inconsistency may be due to relatively small sample
sizes (generally less than 100 [11, 13–18]) and both demographic
and clinical heterogeneity within samples. There is therefore a
need for large population-based neuroimaging studies to better
understand the neural correlates of anhedonia.
Anhedonia may also be associated with abnormalities of
structural connectivity between brain regions, although findings
have not been consistent. A study of negative symptoms in
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schizophrenia reported negative associations between anhedonia
and fractional anisotropy (FA) of the left frontal lobe [19]. Another
study found trait anhedonia was positively correlated with FA in
the cingulum and superior longitudinal fasciculus in patients with
schizophrenia [20]. In addition, Coloigner et al. [21] found that in
depressed patients higher anhedonia was correlated with greater
FA in the superior longitudinal fasciculus and lower FA in the
cingulum, genu of corpus callosum and posterior thalamic
radiation. Further, Yang et al. [22] found that, in healthy controls,
trait anhedonia was associated with higher mean FA in the
superior longitudinal fasciculus, anterior thalamic radiation and
corticospinal tract. Despite the directional inconsistency, abnorm-
alities in these structures tentatively support the assertion that
anhedonia involves abnormal and/or inefficient communication
between brain regions, especially structures within reward circuits,
which might in turn contribute to vulnerability to psychiatric
disorders, such as MDD [8, 9]. It is notable that these studies
[20, 22] of white matter integrity were conducted with relatively
small numbers of participants and, further, most studies on
anhedonia and brain structure have been conducted in selected
clinical samples of MDD or schizophrenia.
In contrast to recent large-scale genome-wide association
studies (GWAS) of MDD and schizophrenia [23, 24], most GWAS
of anhedonia have been small and underpowered. A meta-
analysis of three GWAS (total sample size 6297) reported just a
single locus associated with anhedonia in the discovery sample
and no replication [25]. More recently, the largest GWAS (n=
375,275) of state anhedonia by our group identified 11 novel loci
[6]. So far, to our knowledge, this study is also the first to have
examined the association between PRS-anhedonia and brain
structure [6]. In this paper, Ward et al. [6] examined associations
between PRS-anhedonia and volume of 15 cortical/subcortical
regions of interest and white matter integrity. Significant links
were found with smaller total GMV, smaller volume of the
orbitofrontal cortex, middle frontal gyrus, insula, and anterior
temporal fusiform cortex, as well as worse white matter integrity.
In the present study, we extended the report by Ward et al. [6] by
adding large-scale analyses for the state anhedonia phenotype and
by including additional brain imaging parameters, particularly CT
across the whole brain. We tested for associations between state
anhedonia, PRS-anhedonia and brain structure (whole-surface CT,
subcortical volumes and white matter integrity) and we examined
the specificity of associations. Our hypothesis was that anhedonia
would be associated with individual differences in brain structures,
such as smaller NAcc, thinner anterior cingulate cortex [13, 16], and
poor white matter integrity, and that PRS-anhedonia would also be
associated with reward-related brain regions.
METHODS AND MATERIALS
Participants
The sample included in this study was drawn from UK Biobank, which
gathered extensive questionnaire, physical and cognitive measures, as well
as biological samples from over 500,000 participants. Informed consent
was obtained from all participants, and this study was conducted under
approval from the NHS National Research Ethics Service (UK Biobank
approved applications #6553 and #17689).
At the first imaging visit, a total of 31,064 participants responded to the
question about anhedonia (data field 2060). Participants were excluded for
the following reasons: having a developmental or neurological disorder (see
Table S1 for detailed participant exclusion criteria); not of White European
ancestry; unclear values of anhedonia (responded as ‘prefer not to answer’
or ‘do not know’); age at magnetic resonance imaging (MRI) result missing;
total intracranial volume (ICV, sum of total grey matter, white matter and
ventricular cerebrospinal fluid volume) missing or beyond three standard
deviations from the sample mean. A total of 19,592 participants (ages 45–80
years, 9225 males) were included in this study (see Table 1). For PRS-
anhedonia analyses, participants included in the GWAS of anhedonia were
also excluded to avoid overlap between the train and test samples.
State anhedonia phenotype
As previously described [6], state anhedonia was assessed by a single
question, “Over the past two weeks, how often have you had little interest or
pleasure in doing things?”. Participants could choose from the following
answers: “not at all”; “several days”; “more than half the days”; and “nearly
every day”, which were coded as 0, 1, 2 and 3, respectively. This is identical
to a question from the clinical interview for depression in the Diagnostic
and Statistical Manual of Mental Disorders (DSM–5) and is a part of the
depression scale in the Patient Health Questionnaire [26] and its short
Table 1. Descriptive statistics for demographic variables (N= 19,592).
Variable N (%) or mean ± SD (range)
Gender Male: 9225 (47.09%)
Age (years) 62.60 ± 7.44 (45–80)
Townsend deprivation index at
recruitment (N= 19,577)
−2.06 ± 2.59 (−6.26–9.16)
Childhood traumatic events
(N= 14,100)
1.70 ± 2.35 (0–20)
Adulthood traumatic events
(N= 13,937)
1.97 ± 2.46 (0–20)
Frequency of unenthusiasm/
disinterest in last 2 weeks
Not at all: 16,488 (84.16%)
Several days: 2589 (13.21%)
More than half the days:314 (1.60%)
Nearly every day: 201 (1.03%)
Frequency of depressed mood in
last 2 weeks (N= 19,257)
Not at all: 15,904 (82.59%)
Several days: 2381 (14.7%)
More than half the days:320 (1.66%)
Nearly every day: 202 (1.05%)
Unprescribed/prescribed
medication use
Yes: 3275(16.72%)
No: 16,294 (83.17%)
Prefer not to answer: 23 (0.12%)
Body mass index Underweight: 125 (0.64%)
Normal: 7580 (38.69%)
Overweight: 7916 (40.40%)
Obese: 3542 (18.08%)
Missing: 429 (2.19%)
Current tobacco smoking No: 18,853 (96.23%)
Only occasionally: 442 (2.26%)
Yes, on most or all days: 294 (1.50%)
Prefer not to answer: 3 (0.02%)
Alcohol intake frequency Daily or almost daily: 3283 (16.76%)
Three or four times a week: 5644
(28.81%)
Once or twice a week: 5312 (27.11%)
One to three times a month: 2264
(11.56%)
Special occasions only: 1969 (10.05%)
Never: 1 118 (5.71%)
Prefer not to answer: 2 (0.01%)
Education qualification College or University degree: 8159
(46.65%)
A levels/AS levels or equivalent: 2165
(12.41%)
O levels/GCSEs or equivalent: 3342
(19.14%)
CSEs or equivalent: 643 (3.84%)
NVQ or HND or HNC or equivalent:
1089 (6.11%)
Other professional qualifications eg:
nursing: 882 (5.08%)
Prefer not to answer: 52 (0.30%)
None of the above: 1160 (6.47%)
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versions such as the 2-item Patient Health Questionnaire [27]. This
demonstrates that it is a widely used and representative question in
screening depression.
Brain imaging variables
All neuroimaging data were acquired, pre-processed, quality controlled
and made available by UK Biobank (https://biobank.ctsu.ox.ac.uk/crystal/
crystal/docs/brain_mri.pdf). Details on the acquisition parameters (http://
biobank.ctsu.ox.ac.uk/crystal/refer.cgi?id=1977) and the imaging protocol
(http://biobank.ctsu.ox.ac.uk/crystal/refer.cgi?id=2367) are documented
online and are described within protocol papers [28]. The neuroimaging
data analysed in the current study consisted of: (1) total GMV and total
white matter volume (WMV); (2) subcortical volumes; (3) CT of 31 regions in
each hemisphere from the “Desikan–Killiany–Tourville” (DKT) protocol [29]
over whole brain surface (Fig. S1); and (4) white matter microstructure,
indexed by FA and mean diffusivity (MD). A more detailed description of
these variables is provided within supplementary materials.
Derivation of polygenic risk scores for anhedonia
The polygenic risk score for anhedonia was calculated using LDpred [30]
based on the summary statistics from the GWAS of state anhedonia
mentioned earlier [6]. Of note, the individuals with neuroimaging data in
the current study were excluded from this GWAS [6]. Additional
exclusion criteria for participants in the current study included: over
10% of genetic data missing; self-reported sex did not match genetic
sex; purported sex chromosome aneuploidy was reported; where the
heterozygosity value was a clear outlier; and participants were not of
White European ancestry. In total, 16,696 participants were included in
PRS-anhedonia analyses.
Statistical analysis
Data analysis was conducted using Stata. All brain measures were rescaled
into zero mean and unitary standard deviation. For each brain outcome, as
noted above, data points beyond three standard deviations from the sample
mean were iteratively excluded. False Discovery Rate (FDR) correction at p <
0.05 was applied across 40 volume/thickness measures and white matter
integrity indexes separately using ‘p.adjust’ function in R [31, 32].
For associations between state anhedonia and brain structures,
anhedonia was set as an independent predictor, and each neuroimaging
measure was set as a dependent variable. For bilateral brain measures,
anhedonia × hemisphere interactions were firstly examined in a repeated
measures format to determine whether analysis of left and right
homologous structures separately was required, with sex, age, age2,
hemisphere, ICV and scanner positions on the x, y and z axes set as
covariates. Where there was a significant anhedonia × hemisphere inter-
action, analyses on both lateralised structures were conducted additionally.
In the main analysis, the model included sex, age, age2, total ICV, scanner
positions on the x, y and z axes and hemisphere as fixed effects using
repeated measure design. For whole-brain or single structures, a general
linear model was applied without controlling for hemisphere. For the PRS-
anhedonia analyses, PRS-anhedonia was set as a predictor and genotype
array and the first ten genetic principal components were added, in
addition to the above covariates, for all association tests. Moreover,
considering participants were assessed at two different centers, (16,600 at
the Cheadle imaging center, 2992 at the Newcastle imaging center), we
repeated analyses for anhedonia, PRS-anhedonia and brain structure
adjusting for assessment sites additionally, and examined differences
between the two assessment sites.
Furthermore, we conducted several sensitivity analyses to assess the
robustness of any observed associations with brain structures. Specifically,
we examined (1) the association between anhedonia as a dichotomous
variable and brain measures emerged from main analyses; (2) the
relationship between anhedonia and brain structure after excluding
participants with mental illness (17,489 healthy people); (3) whether
associations found in main analyses remained significant when potential
confounding factors including childhood traumatic events, adulthood
traumatic events, medication use, depressed mood, Townsend social
deprivation index, education qualifications, body mass index, current
tobacco use and alcohol intake frequency were set as additional covariates,
with anhedonia included as another covariate in analyses for PRS-anhedonia
and (4) whether brain structures associated with PRS-anhedonia were
specific compared with the polygenic risk score for MDD. Details and
additional covariates are described in supplementary materials.
RESULTS
Demographics
State anhedonia was significantly negatively correlated with age
(Pearson’s r=−0.114, p < 0.001; Spearman’s rho=−0.117, p <
0.001). Independent t-test showed there was no significant sex
difference for anhedonia (female= 1.201 ± 0.005, male= 1.188 ±
0.005, t= 1.878, p= 0.060; Mann–Whitney U Tests: z= 1.366, p=
0.172). PRS-anhedonia was significantly associated with state
anhedonia (β= 0.031, F(1,16647)= 65.28, R-squared= 0.004, p <
0.001) and PRS-MDD (Pearson’s r= 0.241, p < 0.001). Associations
between anhedonia and potential confounding variables men-
tioned above are shown in supplemental results.
Associations between state anhedonia, brain morphometric
measures and white matter integrity
For whole-brain measures, we found that state anhedonia was
associated with reduced total GMV (β=−0.025, pcorrected < 0.001;
Table S2) and increased total WMV (β= 0.017, pcorrected < 0.001).
For bilateral subcortical and cortical measures, no region
demonstrated significant interaction with hemisphere, therefore
no region was examined separately on different hemispheres
(Table S3). Analyses using the repeated measure design showed
there were significant associations between state anhedonia and
smaller volume of the thalamus (β=−0.040, pcorrected < 0.001;
Table S2) and NAcc (β=−0.051, pcorrected < 0.001), and with
reduced CT in the paracentral gyrus (β=−0.040, pcorrected=
0.010), rostral anterior cingulate cortex (β=−0.042, pcorrected <
0.001; Fig. 1A), precentral (β=−0.033, pcorrected= 0.044), insula
(β=−0.038, pcorrected= 0.010) and opercular part of inferior
frontal gyrus (pars opercularis; β=−0.040, pcorrected= 0.007).
Analyses controlling for assessment sites found same results
(Table S4). Differences between the two assessment centers were
showed in Table S5–S6.
The same models were applied to analyses of white matter
tracts (FA and MD). We firstly tested the interaction of hemisphere
and state anhedonia and found significant effects on MD of the
acoustic radiation (β=−0.050, pcorrected= 0.012; Table S3) and MD
of the uncinate fasciculus (β= 0.032, pcorrected= 0.012). Therefore,
Fig. 1 Cortical maps of associations between cortical thickness,
state anhedonia and the polygenic risk score for anhedonia,
rendered on the left hemisphere. A Regions associated with state
anhedonia; B Regions associated with the polygenic risk score for
anhedonia. Only regions survived multiple comparisons correction
were shown. Negative Z values indicate cortical thinning in brain
regions.
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the left and right MD values of the two tracts were also tested
(Table S2). We found anhedonia was associated with reduced FA
in the forceps major (β=−0.043, pcorrected= 0.010; Table S2;
Fig. 2), anterior thalamic radiation (β=−0.039, pcorrected= 0.012),
inferior longitudinal fasciculus (β=−0.038, pcorrected= 0.014),
posterior thalamic radiation (β=−0.055, pcorrected < 0.001) and
superior longitudinal fasciculus (β=−0.036, pcorrected= 0.022). In
addition, state anhedonia was associated with increased MD in the
forceps major (β= 0.045, pcorrected= 0.006), forceps minor (β=
0.037, pcorrected= 0.017), left acoustic radiation (β= 0.035,
pcorrected= 0.030), anterior thalamic radiation (β= 0.064, pcorrected
< 0.001), cingulate gyrus part of cingulum (β= 0.052, pcorrected <
0.001), corticospinal tract (β= 0.051, pcorrected < 0.001), inferior
fronto-occipital fasciculus (β= 0.049, pcorrected= 0.001), inferior
longitudinal fasciculus (β= 0.045, pcorrected= 0.003), posterior
thalamic radiation (β= 0.046, pcorrected < 0.001), superior long-
itudinal fasciculus (β= 0.064, pcorrected < 0.001), superior thalamic
radiation (β= 0.066, pcorrected < 0.001), uncinate fasciculus (β=
0.042, pcorrected= 0.003), left uncinate fasciculus (β= 0.029,
pcorrected= 0.045) and right uncinate fasciculus (β= 0.056,
pcorrected < 0.001).
PRS-anhedonia, brain morphometric measures and white
matter integrity
Analyses of whole-brain measures found that PRS-anhedonia was
associated with lower total GMV (β=−0.014, pcorrected < 0.001;
Table S2) and higher total WMV (β= 0.012, pcorrected < 0.001).
There was no significant interaction between PRS-anhedonia and
hemisphere on subcortical volumes, as well as regional CT
(Table S3). We found significantly negative associations between
PRS-anhedonia and CT in the insula cortex (β=−0.030, pcorrected
< 0.001; Table S2; Fig. 1B), parahippocampal cortex (β=−0.032,
pcorrected < 0.001) and superior temporal gyrus (β=−0.024,
pcorrected= 0.008). Same results were found when the assessment
site was additionally adjusted for (Table S4). Differences between
the two assessment centers were showed in Tables S5 and S7.
None of the measures of white matter integrity demonstrated
significant interaction of hemisphere and PRS-anhedonia (Table S3).
PRS-anhedonia was associated with lower FA in the forceps minor (β
=−0.022, pcorrected= 0.021; Table S2; Fig. 2) and posterior thalamic
radiation (β=−0.020, pcorrected= 0.023). In addition, analyses for MD
values found positive associations with the forceps minor (β= 0.023,
pcorrected= 0.021), middle cerebellar peduncle (β= 0.025, pcorrected=
0.021), anterior thalamic radiation (β= 0.019, pcorrected= 0.023),
cingulate gyrus part of cingulum (β= 0.022, pcorrected= 0.021), inferior
fronto-occipital fasciculus (β= 0.021, pcorrected= 0.021), inferior long-
itudinal fasciculus (β= 0.018, pcorrected= 0.038), posterior thalamic
radiation (β= 0.027, pcorrected < 0.001), superior longitudinal fasciculus
(β= 0.022, pcorrected= 0.021), superior thalamic radiation (β= 0.018,
pcorrected= 0.027) and uncinate fasciculus (β= 0.017, pcorrected=
0.035).
Sensitivity analyses: associations between state anhedonia
(as a dichotomous variable) and brain structure
In general, analyses for anhedonia as a dichotomous variable
found similar results (Table S8). However, compared to previous
results, the paracentral gyrus (β=−0.035, puncorrected= 0.047) and
insula (β=−0.034, puncorrected= 0.048) became only nominally
significant before FDR correction while precentral cortex (β=
−0.024, puncorrected= 0.167) was no longer significant. Associations
with MD in the left acoustic radiation (β= 0.037, puncorrected=
0.068) and left uncinate fasciculus (β= 0.029, puncorrected= 0.104)
were also no longer significant. See supplemental materials for
more details.
Sensitivity analyses: associations between state anhedonia
(linear variable) and brain structure in healthy participants
For total GMV/WMV, subcortical volumes and regional CT, we found
similar results. However, for white matter integrity, only FA in the
posterior thalamic radiation (β=−0.045, puncorrected= 0.048;
Table S9) and MD in the superior thalamic radiation remained
significant (β= 0.043, puncorrected= 0.048). In addition, we found
nominally significant interaction effect on several white matter
tracts before FDR correction (Table S10; supplemental results). The
Fig. S2 illustrates the interaction between anhedonia and mental
health status on several white matter tracts. Briefly, similar patterns
Fig. 2 Associations between anhedonia (left panel) and polygenic risk for anhedonia (right panel) and white matter integrity. The y-axis
represents the white matter tracts tested in our analyses. The x-axis represents the absolute Z values for anhedonia and polygenic risk for
anhedonia in regression models. Fractional anisotropy and mean diffusivity are separately shown in red and blue. The absolute Z= 2.4 black
dashed lines indicates significance. This value was chosen according to the significance of each regression model. In the left panel, bars to the
left of the black dashed line indicate significant associations between anhedonia and corresponding white matter tracts. In the right panel,
bars to the right of the black dashed line are significant, indicating associations between polygenic risk for anhedonia and white matter tracts.
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were found in participants with and without mental illness, but the
association was stronger in those with mental illness.
Sensitivity analyses: associations between state anhedonia,
PRS-anhedonia and brain structure controlling for potential
confounding factors
For state anhedonia, when additional covariates were added in
the model, we found significant associations with increased total
WMV (β= 0.018, pcorrected= 0.022; Table S11), smaller total GMV
(β=−0.025, pcorrected= 0.009) and nucleus accumbens (β=
−0.043, pcorrected= 0.038), as well as reduced thickness in the
paracentral cortex (β=−0.062, pcorrected= 0.011), pars opercularis
(β=−0.070, pcorrected= 0.009) and precentral cortex (β=−0.063,
pcorrected= 0.011). For white matter integrity, none of those tracts
survived FDR correction.
For PRS-anhedonia, we found PRS-anhedonia was still signifi-
cantly associated with total GMW (β=−0.007, pcorrected= 0.020;
Table S12), total WMV (β= 0.009, pcorrected= 0.005), as well as CT
in the parahippocampal cortex (β=−0.031, pcorrected < 0.001),
superior temporal cortex (β=−0.023, pcorrected= 0.011) and insula
(β=−0.027, pcorrected= 0.005), while associations with FA/MD of
white matter tracts were no longer significant.
Associations between PRS-MDD and brain structure
Analyses of whole-brain measures and regional CT found
nominally significant association with CT in the lateral occipital
cortex (β= 0.017, puncorrected= 0.018; Table S13), posterior cingu-
late cortex (β=−0.016, puncorrected= 0.013) and insula (β=
−0.015, puncorrected= 0.036), but none of them survived FDR
correction. However, there were significant associations with
lower FA or higher MD of several white matter tracts such as the
anterior thalamic radiation and the cingulate gyrus part of
cingulum. See supplemental results for further details.
DISCUSSION
Overall, we found that the phenotype of state anhedonia and the
PRS-anhedonia were both associated with individual differences in
brain structure. State anhedonia was associated with smaller
volumes in the thalamus and NAcc, and with thinner CT in the
paracentral cortex, the opercular part of inferior frontal gyrus,
precentral cortex, insula and rostral anterior cingulate cortex, as
well as poor integrity of many white matter tracts. Higher
polygenic risk for anhedonia was associated with reduced total
GMV, increased total WMV, thinner parahippocampal cortex,
superior temporal cortex and insula cortex, plus poorer white
matter integrity. Sensitivity analyses for anhedonia found con-
sistent associations with total GMV, total WMV, NAcc and CT in
pars opercularis. Similarly, associations between PRS-anhedonia
and total GMV, total WMV and regional CT remined significant
when potential confounding factors were considered.
State anhedonia and brain structures
Consistent with previous studies, the main analyses for state
anhedonia found associations with loss of grey matter in the
thalamus, NAcc and rostral anterior cingulate cortex, consistent
with the fronto-striatal reward circuit hypothesis [8, 33]. Previous
studies have demonstrated associations with reduced volume or CT
in these regions within non-clinical populations [16, 17], as well as
in patients with schizophrenia and MDD [13, 34–36]. These brain
structures are also key regions in the subcortical-cortical midline
system, which has been related to abnormalities of the self in
patients with MDD [37]. A recent study found that the NAcc was
also associated with auditory hallucinations [38]. Furthermore, the
negative associations between state anhedonia and CT in the
paracentral cortex and pars opercularis are consistent with findings
in patients with schizophrenia [12,13,39,40,], corresponding to the
potential role of these areas in reward processing [41, 42].
Additionally, we found that state anhedonia was associated with
poor white matter integrity, specifically lower FA and higher MD
values within several white matter tracts. Unlike previous contra-
dictory findings, the results for different tracts in this large sample
were more consistent. Regarding specific white matter tracts, altered
FA in the cingulum, superior longitudinal fasciculus, anterior
thalamic radiation and corticospinal tract have been reported in
relation to trait anhedonia [20, 22], in line with their function in
reward processing [43]. Previous studies in patients with MDD and
schizophrenia also reported worse white matter integrity of many
tracts, such as the superior longitudinal fasciculus and anterior
thalamic radiation observed in this study [44–46]. However, it is
noteworthy that many anhedonia-related white matter tracts were
no longer statistically significant when participants with mental
illness were excluded. In addition, interaction analyses revealed
stronger associations in those with mental illness, suggesting that
the findings of white matter integrity might be driven by
participants with mental illness. More studies are needed to
elucidate the relationship between anhedonia and white matter in
both healthy people and patients with mental illness.
PRS-anhedonia and brain structures
Our analyses for PRS-anhedonia found associations with reduced
total GMV and increased total WMV, along with reduced CT in the
parahippocampal cortex, superior temporal gyrus and insula cortex.
Previous findings on total GMV and total WMV in relation to PRS for
schizophrenia/MDD are inconsistent. One study [47] reported
reduced total brain volume and total WMV in relation to PRS for
schizophrenia and no significant association with GMV, while later
research found no associations with GMV or WMV [48–50].
However, it is notable that these studies had relatively small
sample sizes (ranging from 152 to 1470) and may have lacked
power to detect associations.
Regarding subcortical volume measures, we found no significant
association with PRS-anhedonia, consistent with previous studies of
PRS for schizophrenia and MDD [48, 50, 51]. Although anhedonia
was found to be genetically correlated with NAcc volume [52], we
failed to detect a significant association. For cortical regions, our
prior work [6] on GMV also reported negative associations in the
insular and temporal cortex, in addition to the findings on CT
described in the current study. Importantly, in comparison to
findings for PRS-MDD, associations with these brain areas were
specific to PRS-anhedonia, indicating the potential contribution of
genetic risk for anhedonia as a tool to reveal vulnerability
biomarkers for mental illness. Previous studies of CT in patients
with schizophrenia and MDD have also reported widespread
thinning of the cortex, including parahippocampal cortex, superior
temporal gyrus and insula cortex [40, 53]. Moreover, studies on
polygenic risk for mental illness genetically related to anhedonia
(PRS for schizophrenia) also point to links with reduced insular CT
[54]. A meta-analysis for emotion/reward tasks in relation to
anhedonia also observed associations with altered activation in
widespread regions including parahippocampal cortex, superior
temporal gyrus and insula cortex in healthy controls and in patients
with schizophrenia or MDD [55]. These findings support the
association between anhedonia and reward-related processes.
PRS-anhedonia was also associated with poor white matter
integrity. We found lower FA and higher MD of several white
matter tracts in relation to PRS-anhedonia, such as the superior
longitudinal fasciculus, the cingulate gyrus part of cingulum, and
the posterior thalamic radiation. This is in line with the previously
reported results by Ward et al. [6]. Given that there are potential
shared genetic components between white matter integrity and
MDD and schizophrenia [56–58]—and genetic correlations
between anhedonia, MDD and schizophrenia [6, 25]—it is perhaps
not surprising that we observed associations between polygenic
risk for anhedonia and white matter indices. In over 9000
participants from UK Biobank, Shen et al. [59] recently found
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PRS for MDD was associated with white matter integrity of several
tracts, such as the superior longitudinal fasciculus, the cingulate
gyrus part of cingulum, the inferior fronto-occipital fasciculus and
superior thalamic radiation, which were associated with PRS-
anhedonia in our study. Previous studies on PRS for MDD have
also reported associations with decreased white matter integrity,
most notably in the superior longitudinal fasciculus, cingulum and
thalamic radiations [60–62], although null findings have also been
reported with respect to polygenic risk for MDD or schizophrenia
[48, 63]. Together with our findings of worse white matter integrity
in relation to state anhedonia, white matter tracts associated with
PRS-anhedonia could represent a biomarker of vulnerability to
anhedonia and psychiatric disorders.
We found an overlap of brain structural correlates between
state anhedonia and PRS-anhedonia. The results of morphometric
measures of brain regions after FDR correction indicated
heterogeneity of related regions, with only a weak overlap (insula
CT) identified, and it became non-significant when potential
confounding factors were considered. For white matter integrity,
we found common associations with many white matter tracts
such as the forceps minor, superior longitudinal fasciculus,
anterior thalamic radiation and posterior thalamic radiation,
although they disappeared when those additional covariates
were added in the model. Combining the main results and
sensitivity analyses, total GMV and total WMV showed the
strongest association with both state anhedonia and PRS-
anhedonia. Considering previous studies reporting mediating
roles of brain measures in the relationship between genetic risk
and psychiatric symptoms [59, 64], and the overlapping strong
associations found in this study, we therefore also conducted
mediation analyses to explore whether the two brain measures or
state anhedonia were potential mediation candidates of genetic
risk for anhedonia. Details of the statistics and results are provided
within supplementary materials. Briefly, our findings support that
total GMV, total WMV and state anhedonia may mediate the
influence of genetic loading for anhedonia (Fig. S3). Future studies
are needed to clarify the potential mechanisms linking brain
alterations, state anhedonia and genetic risk for anhedonia.
Integrating findings of morphometric measures and white
matter integrity
This study performed multimodal structural brain imaging
analyses on subcortical volume, regional CT and white matter
integrity, which enabled us to carry out more comprehensive
analyses. Although the morphometric measures and white matter
indices are distinct and were analysed in parallel, the results
together suggest a role for reward circuits.
The thalamus, NAcc and rostral anterior cingulate cortex lie
within the reward circuit. White matter tracts such as the cingulum
bundle and the anterior thalamic radiation are also involved in
reward processing. Specifically, the cingulum is the most
prominent tract in the limbic system, directly connecting several
reward-related regions, such as the anterior cingulate cortex,
orbital frontal cortex, hippocampus, parahippocampal region and
thalamic nucleus, and has been previously reported to be involved
in executive cognition and emotion processing [43]. In addition,
the anterior thalamic radiation connects the thalamus, prefrontal
cortex, and ventral periaqueductal grey, with fibres extending to
temporal medial regions (e.g., amygdala and hippocampus) [65].
Its horizontal fibres are connected to areas that are also relevant in
reward processing, such as the rostral anterior cingulate gyrus.
Moreover, white matter integrity in the cingulate, anterior
thalamic radiation and inferior fronto-occipital fasciculus, amongst
others, has been found to be positively correlated with reward-
related activity in NAcc [66]. Overall, morphometric alterations
correspond to poor integrity of reward-related white matter tracts,
supporting the reward circuit hypothesis of anhedonia [8, 33].
Associations independent of potential confounding factors
Some external factors, such as childhood trauma and antipsychotic
medication, may contribute to brain structural alterations [67, 68].
However, the influence of potential confounding factors associated
with brain abnormalities in psychiatric disorders has often been
neglected. Most previous studies on PRS for MDD and schizophrenia
did not consider those factors [54, 69, 70], and this was the case in
prior PRS-anhedonia analyses [6]. Our sensitivity analyses controlled
for childhood traumatic events, adulthood traumatic events,
medication use, depressed mood, Townsend social deprivation
index, education qualification, body mass index, current tobacco use
and alcohol intake frequency. The observed associations between
anhedonia and total GMV/WMV, NAcc and CT in pars opercularis, and
the associations between PRS-anhedonia and total GMV/WMV, CT
within the parahippocampal cortex, superior temporal gyrus and
insula were independent of these variables.
It should also be noted that the associations between
anhedonia, PRS-anhedonia and white matter tracts were not
statistically significant when these covariates were considered.
Previous studies have demonstrated associations between factors
such as childhood trauma, medication use, and white matter
integrity [71, 72]. Future studies focusing on biomarkers of
psychiatry disorders should consider the effects of these potential
confounding factors and gene–environment interactions.
Strengths and limitations
To our knowledge, this is the largest study to test for associations
between anhedonia and brain parameters within a single population-
based sample, and the first study to examine associations between
anhedonia, PRS-anhedonia, and regional CT of the whole brain
surface. Our supplementary analyses considered other covariates such
as childhood traumatic events, medication use, depressed mood,
tobacco use and alcohol intake frequency, highlighting robust
associations driven by genetic risk (PRS-anhedonia).
Despite these strengths, there are some important potential
limitations. Firstly, we note that participants in this study were
aged from 45 to 80, which means that cumulative environ-
mental risk may have contributed to some associations.
Secondly, we only included participants of White European
descent. Although the genetic basis of psychiatry disorders
might be partially shared between different populations [73, 74],
we should be cautious to generalize these results to other
populations. Thirdly, considering that anhedonia may also
manifest in childhood, before the onset of psychiatric disorders
[7, 75], further consideration of how polygenic risk for
anhedonia may influence child or adolescent brain development
and brain changes over longer developmental periods will be
important to further understand the nature of the relationship
between anhedonia and brain structure. Moreover, the mea-
surement of anhedonia was a single self-report item. A
dimensional measure of anhedonia, such as the Chapman
Physical and Social Anhedonia Scale [3] might prove to be a
more informative phenotype in future work. Finally, the effect of
the PRS-anhedonia is very modest; however, this is in line with
those observed for other complex mental health traits [76, 77].
CONCLUSION
In summary, we found that the phenotype of anhedonia and
genetic risk for anhedonia were both associated with brain
structures within a large population-based sample of 19,592
people. This included reduced volume/CT of total grey/white
matter, thalamus, NAcc, paracentral gyrus, pars opercularis, rostral
anterior cingulate cortex, parahippocampal cortex, superior
temporal gyrus and insula, as well as worse white matter integrity.
Overall, our findings suggest that reward-related brain structures
are associated with anhedonia and its genetic risk and highlight
X. Zhu et al.
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potential neuroanatomical markers of risk for psychopathology
across a range of psychiatric disorders.
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